Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies
Vivek Subbiah, Nicholas O. Iannotti, Martin E Gutierrez, David Carl Smith, Luis Roberto Féliz, Christine Francis Lihou and 4 more
- Rank
- 26 of 3,616
- Percentile
- top 0.8%
- Where
- Annals of Oncology, 2022
- Citations
- 201
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.